During the past decade, Policlinico di Monza conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Policlinico di Monza" #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Boston Scientific Corporation" with 1 trials sponsored, "C. R. Bard" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Federico II University" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Policlinico di Monza" #1 collaborator was "BUPA Foundation" with 1 trials as a collaborator, "Erasmus Medical Center" with 1 trials as a collaborator, "NHS Health Technology Assessment Programme" with 1 trials as a collaborator, "Policlinico di Monza" with 1 trials as a collaborator and "University Clinical Hospital of Bialystok" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Policlinico di Monza" are "Arterial Occlusive Diseases" (2 trials), "Heart Failure" (2 trials), "Peripheral Arterial Disease" (2 trials), "Aortic Valve Stenosis" (1 trials) and "Arteriosclerosis" (1 trials). Many other conditions were trialed in "Policlinico di Monza" in a lesser frequency.

Most popular intervention types in "Policlinico di Monza" are "Device" (6 trials), "Drug" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "ADI-PEG 20 (arginine deiminase formulated with polyethylene glycol)" (1 trials), "Best Supportive Care" (1 trials), "CEA, CAS" (1 trials), "Drug Coated Balloon" (1 trials) and "EXIST 6F NiTi Stent System FLEX" (1 trials). Other intervention names were less common.

The vast majority of trials in "Policlinico di Monza" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Policlinico di Monza". 2 are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Policlinico di Monza, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Policlinico di Monza, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Policlinico di Monza has several departments that took part in Clinical trials: "Policlinico Di Monza - Uo Cardiol. Clinica E Scompenso Cardiaco" - 5 trials